BRIXADI is a prescription buprenorphine treatment for adults with moderate to severe opioid use disorder, including dependence on prescription or illicit opioids. It is an extended-release injection administered under the skin by a healthcare professional and is available in weekly and monthly formulations. Treatment is intended for people who have started buprenorphine with a sublingual tablet or buccal film, or who are already receiving buprenorphine, and should be combined with counseling and behavioral therapy.

The BRIXADI Treatment Provider Locator, provided by Braeburn, helps US residents search for listed healthcare professionals by city, state, or ZIP code, search radius, and service type. Results may include physicians, nurse practitioners, and physician assistants at clinics, hospitals, private practices, telehealth services, and other treatment settings. Listed providers attest to experience treating opioid use disorder, recent BRIXADI prescribing or administration, and acceptance of new patients. The locator does not guarantee completeness or endorse providers, so patients should assess whether a professional meets their needs.